Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Ironwood Pharmaceuti (IRWD)

Ironwood Pharmaceuti (IRWD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,724,575
  • Shares Outstanding, K 156,495
  • Annual Sales, $ 346,640 K
  • Annual Income, $ -282,370 K
  • 60-Month Beta 1.80
  • Price/Sales 4.92
  • Price/Cash Flow N/A
  • Price/Book N/A

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/19
See More
  • Average Estimate 0.22
  • Number of Estimates 4
  • High Estimate 0.27
  • Low Estimate 0.19
  • Prior Year -0.02
  • Growth Rate Est. (year over year) +1,200.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
8.57 +29.64%
on 10/14/19
11.14 -0.27%
on 11/11/19
+2.30 (+26.11%)
since 10/11/19
3-Month
7.91 +40.46%
on 10/02/19
11.14 -0.27%
on 11/11/19
+1.65 (+17.44%)
since 08/09/19
52-Week
7.91 +40.46%
on 10/02/19
15.21 -26.96%
on 02/15/19
-0.77 (-6.48%)
since 11/09/18

Most Recent Stories

More News
FibroGen (FGEN) Soars: Stock Adds 9.6% in Session

FibroGen (FGEN) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

IRWD : 11.11 (+0.82%)
FGEN : 35.40 (-14.94%)
Ironwood Pharmaceuticals, Inc. (IRWD) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Ironwood Pharmaceuticals, Inc. (IRWD).

IRWD : 11.11 (+0.82%)
Pharma Sector Tops in October: Best ETFs & Stocks

Pharma sector wins in October, making these ETFs and stocks winners.

PPH : 59.45 (-0.52%)
XPH : 38.57 (-0.59%)
PJP : 60.08 (-0.28%)
ALXN : 109.01 (-1.61%)
BIIB : 294.14 (+0.30%)
ACHN : 6.35 (-0.16%)
DERM : 8.05 (-2.19%)
GLYC : 5.90 (-5.45%)
RIGL : 2.31 (+2.67%)
IRWD : 11.11 (+0.82%)
Jazz Pharma (JAZZ) Q3 Earnings Beat, Xyrem Drives Sales

Jazz Pharmaceuticals (JAZZ) beats third-quarter 2019 earnings and revenue estimates and raises its guidance for 2019.

IRWD : 11.11 (+0.82%)
DERM : 8.05 (-2.19%)
JAZZ : 130.88 (+0.57%)
FGEN : 35.40 (-14.94%)
Surging Earnings Estimates Signal Upside for Ironwood (IRWD) Stock

Ironwood (IRWD) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

IRWD : 11.11 (+0.82%)
Ironwood Pharmaceuticals to Present at the 28th Annual Credit Suisse Healthcare Conference

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) will present a corporate update at the 28th Annual Credit Suisse Healthcare Conference on Tuesday, November 12, 2019 at 4:10 p.m. Mountain Standard Time (6:10...

IRWD : 11.11 (+0.82%)
Irritable Bowel Syndrome (IBS) Therapeutics Market Analysed by Business Growth, Development Factors and Future Trends by 2026

Ameco Research in its report titled, "," offers comprehensive insights and detailed research on the global Irritable Bowel Syndrome (IBS) Therapeutics market over the forecast period 2019 - 2026. The report...

ABT : 83.76 (+0.02%)
ALPMF : 16.8000 (-1.47%)
GSK : 44.26 (-0.36%)
IRWD : 11.11 (+0.82%)
NVS : 88.63 (+0.29%)
SCMP : 18.05 (+0.28%)
SGYP : 0.03 (-52.00%)
VRX.TO : 30.80 (-3.33%)
Karyopharm Thera has the Best Relative Performance in the Biotechnology Industry (KPTI , IRWD , SRPT , TGTX , DVAX )

Here are the top 5 stocks in the Biotechnology industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

IRWD : 11.11 (+0.82%)
KPTI : 15.28 (+3.80%)
SRPT : 94.78 (-1.56%)
Bullish Two Hundred Day Moving Average Cross - IRWD

In trading on Friday, shares of Ironwood Pharmaceuticals Inc crossed above their 200 day moving average of $10.52, changing hands as high as $10.55 per share. Ironwood Pharmaceuticals Inc shares are...

IRWD : 11.11 (+0.82%)
Ironwood (IRWD) Beats on Q3 Earnings & Revenues, Ups '19 View

Ironwood (IRWD) witnesses strong demand for Linzess in the third quarter as well.

AGN : 181.58 (+0.17%)
AZN : 46.88 (-0.80%)
IRWD : 11.11 (+0.82%)
CYCN : 2.06 (+8.42%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade IRWD with:

Business Summary

Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company that discovers, develops, and intends to commercialize innovative human medicines. The Company's first in class compound, Linaclotide, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome...

See More

Key Turning Points

2nd Resistance Point 11.35
1st Resistance Point 11.23
Last Price 11.11
1st Support Level 10.90
2nd Support Level 10.69

See More

52-Week High 15.21
Fibonacci 61.8% 12.42
Fibonacci 50% 11.56
Last Price 11.11
Fibonacci 38.2% 10.70
52-Week Low 7.91

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar